AMEND wishes to support research and is providing up to £10,000 per year (subject to available funds) to enable medical researchers to supplement an existing project or pump-prime new research ideas. The successful project must be specifically directed to the study of endocrine tumours within the context of multiple endocrine neoplasia. This award is currently only available to projects carried out within the United Kingdom and Eire.

We are delighted to be able to offer a total 2019 Research Award Fund of £30,000, thanks to the incredible fundraising efforts of our members and supporters.  £20,000 will be available specifically for projects looking at MEN1-related research in memory of Nick Fayers, and £10,000 will be available as usual for projects into any of the conditions associated with AMEND (MEN1, MEN2A, MEN2B, SDHx, MTC and ACC – and the tumours related to these conditions).

We now invite applications to be submitted by the deadline of 30 April 2019 using the form below:

For further information and criteria, please view the application form:

AMEND is a National Institute for Health Research (NIHR) Non-Commercial Partner

Appropriate research studies funded through AMEND’s Research Fund are now automatically eligible for NIHR Clinical Research Network (CRN) support and therefore entitled to:

Please note that to be eligible for NIHR CRN support any research study we fund must also meet the standard study eligibility criteria, namely that it:

Current and Past Award(s)